604 PERCUTANEOUS TRANSCATHETER CLOSURE OF SYMPTOMATIC PATENT FORAMEN OVALE IN PATIENT WITH INFERIOR VENA CAVA INTERRUPTION
نویسندگان
چکیده
Abstract Percutaneous closure of a patent forame ovale (PFO) is indicated in selected patients with confirmed cryptogenic stroke, transient ischemic attack (TIA), or systemic embolism and an estimated high probability casual role the PFO as assessed by clinical, anatomical imaging features. This procedure usually undertaken from femoral vein. In this case, patient was affected vena cava agenesis compensatory enlargement azygos We performed percutaneous using 9F jugular vein access. advanced straight guide trough foramen Multipurpose 6F catheter supported Destino Oscor 8F. Then we changed Amplatz Super-Stiff 0.035" left ventricle, on which Mullins trans-septal advanced. Finally delivered Amplatzer Multifenestrated Septal Occluder "Cribriform" 25/25 mm. our it impossible to perform classic access due inferior agenesis. Performing right internal venous approach technically challenging but safe possible standard equipment normally present Catheterization Laboratory. rare cases indication for lack through veins, alternative techniques shelf materials help overcoming anatomies. The use steerable critical engaging unfavourable angulation. nitinol double disk devices effective.
منابع مشابه
Transcatheter Closure of Patent Foramen Ovale.
P atent foramen ovale (PFO), the most common postnatal residue of the fetal circulation, has for many years been considered to have almost no clinical relevance. In an autopsy study from the Mayo Clinic, PFO was found in 27% of 965 normal human hearts, with an incidence declining with increasing age (34% in the first three decades and 20% in the ninth and 10th decades).' PFO size ranged between...
متن کاملPercutaneous closure of patent foramen ovale.
AIM To review the safety and efficacy of percutaneous closure of patent foramen ovale (PFO) in symptomatic patients without the use of general anaesthesia or echocardiographic guidance. METHOD All patients accepted for percutaneous PFO closure by our service from August 2002 to August 2004 were included. Patient demographics and clinical information were obtained from clinical records and by ...
متن کاملTriple percutaneous patent foramen ovale closure
Percutaneous patent foramen ovale (PFO) closure is mainly performed for secondary prevention of presumed paradoxical embolism. Since a residual shunt has been associated with recurrent events, complete PFO closure is desirable. We report the first case of ultimately successful percutaneous PFO closure using successively 3 Amplatzer PFO devices.
متن کاملEustachian valve interfering with transcatheter closure of patent foramen ovale.
A prominent Eustachian valve (EV) is a common finding in patients with a patent foramen ovale (PFO). Its presence might compromise transcatheter closure of the PFO.
متن کاملIschemic Stroke in Patients with Percutaneous Patent Foramen Ovale Closure
Background: The prevalence of patent foramen ovale is approximately 50% in patients who have suffered a cryptogenic stroke. The recurrence of ischemic stroke after percutaneous patent foramen ovale closure is approximately 1% per year. Objective: The aim of this study was to evaluate the prevalence of recurrent ischemic stroke in our population undergoing percutaneous patent foramen ovale closu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal Supplements
سال: 2022
ISSN: ['1520-765X', '1554-2815']
DOI: https://doi.org/10.1093/eurheartjsupp/suac121.319